Trastuzumab Deruxtecan With Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study.
- E Hamilton
- , Galsky MD
- , S Ochsenreither
- , Conte G Del
- , M Martín
- , de Miguel MJ
- , Yu EY
- , Anja Williams
- , M Gion
- , Tan AR
- , L Agrawal
- , A Rutten
- , Machiels JP
- , S Hurvitz
- , Philip Debruyne
- General Hospital Groeninge
- Anglia Ruskin University
Research output: Contribution to journal › Article › peer-review
4
Downloads
(Pure)